Personalis, Inc. (PSNL)
Last updated: 2026-10-20 09:08:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Personalis, Inc. (PSNL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $15.71, with a market capitalization of $1.67B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.96 to $18.89. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.67B | |
$15.63 | |
$53.46 | |
$0.89 | |
$15.88 | |
100.00 | |
2.92M | |
-- | |
$18.89 | |
$4.96 | |
-- | |
-- |
Personalis, Inc. (PSNL) Pre-Market Stock Price
Personalis, Inc. (PSNL) is trading at $15.71 in pre-market trading as of 2026-10-20 08:13:00, down 1.07% ($0.17) from the previous close of $15.88
Pre-market trading shows how investors are pricing PSNL before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Personalis, Inc. (PSNL) 7-Day Stock Price Change
Over the past seven days, Personalis, Inc. (PSNL) moved from $16.00 to $15.71, representing a decline of 1.81% ($0.29).
The stock traded between $15.51 and $16.24 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 2.82 million shares, up versus the previous seven-day period, indicating higher trading activity.
PSNL 52-Week Price Position
Position in Range: 77.2%
PSNL is currently trading at $15.71, placing it 77.2% of the way from its 52-week low of $4.96 to its 52-week high of $18.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Personalis, Inc. (PSNL)?
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Personalis, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 260 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Personalis, Inc. (PSNL) Stock on MEXC
Eligible investors can buy real shares of Personalis, Inc. (PSNL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Personalis, Inc. (PSNL) stock price today?
2.Is PSNL stock going up or down today?
3.What is PSNL pre-market price?
4.What is PSNL after-hours price?
5.Is PSNL stock trading now?
6.Where does PSNL sit relative to its 52-week high and low?
7.What sector is Personalis, Inc. in?
8.What is Personalis, Inc.'s market capitalization and where is it listed?
9.How is PSNL valued in terms of P/E ratio and EPS?
10.Does Personalis, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PSNL Stock Calculator
Estimate the value between PSNL shares and USD.
PSNL Shares to USD
1.00 PSNL shares = 15.71 USD
Calculations are estimates based on the latest available price and are for reference only.


